HIMS - Company ID 0001773751
The table below shows Hims & Hers Health, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $608.10M | $598.98M | $544.83M | $586.01M | $401.56M | $315.65M |
| Cost of revenue | $211.32M | $156.92M | $128.64M | $155.32M | $83.67M | $59.03M |
| Gross profit | $396.79M | $442.06M | $416.20M | $430.69M | $317.89M | $256.61M |
| R&D | - | - | - | - | - | - |
Hims & Hers Health, Inc. reported annual revenue of $2.35B for fiscal year 2025. That is up 59.0% from $1.48B in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $82.56M (FY 2019) to $2.35B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $109.67M | $80.68M | $67.27M | $48.61M | $44.62M | $40.55M |
| Operating income | -$78.32M | $11.81M | $26.72M | $57.90M | $22.37M | $11.03M |
| Income tax | -$9.44M | -$3.55M | -$9.65M | $11.01M | -$51.99M | $127.00K |
| Net income | -$92.11M | $15.77M | $42.51M | $49.48M | $75.59M | $13.30M |
| EPS (diluted) | -$0.40 | $0.06 | $0.17 | $0.20 | $0.32 | $0.06 |